TOSI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.434
EU - Europa 16.092
AS - Asia 13.769
SA - Sud America 1.945
AF - Africa 346
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 19
Totale 61.660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.060
GB - Regno Unito 4.580
IT - Italia 3.949
SG - Singapore 3.909
CN - Cina 3.862
SE - Svezia 3.077
HK - Hong Kong 1.863
BR - Brasile 1.464
VN - Vietnam 1.453
DE - Germania 914
RU - Federazione Russa 635
FI - Finlandia 614
TR - Turchia 603
UA - Ucraina 591
FR - Francia 533
KR - Corea 468
IN - India 370
BG - Bulgaria 227
NL - Olanda 176
ID - Indonesia 164
BD - Bangladesh 161
CA - Canada 159
AR - Argentina 153
IQ - Iraq 140
JP - Giappone 125
MX - Messico 117
ES - Italia 111
IE - Irlanda 103
ZA - Sudafrica 103
PL - Polonia 83
BE - Belgio 82
PK - Pakistan 81
RO - Romania 78
CO - Colombia 77
EC - Ecuador 72
AE - Emirati Arabi Uniti 69
LT - Lituania 64
MY - Malesia 57
VE - Venezuela 54
CH - Svizzera 53
EG - Egitto 47
IR - Iran 46
IL - Israele 45
AU - Australia 43
UZ - Uzbekistan 40
CL - Cile 39
MA - Marocco 39
PH - Filippine 34
PY - Paraguay 33
DZ - Algeria 31
TN - Tunisia 31
AT - Austria 28
JO - Giordania 28
SA - Arabia Saudita 28
CZ - Repubblica Ceca 27
GR - Grecia 26
KE - Kenya 24
TW - Taiwan 24
NP - Nepal 23
PT - Portogallo 22
TH - Thailandia 22
AZ - Azerbaigian 21
KZ - Kazakistan 20
EE - Estonia 19
UY - Uruguay 18
ET - Etiopia 17
PE - Perù 17
BO - Bolivia 16
CR - Costa Rica 15
JM - Giamaica 15
SN - Senegal 15
DK - Danimarca 14
EU - Europa 14
BY - Bielorussia 12
AL - Albania 11
DO - Repubblica Dominicana 11
LB - Libano 11
NZ - Nuova Zelanda 11
OM - Oman 11
TT - Trinidad e Tobago 11
HU - Ungheria 10
KG - Kirghizistan 10
PA - Panama 10
RS - Serbia 10
NO - Norvegia 9
HN - Honduras 8
KH - Cambogia 8
LY - Libia 8
PS - Palestinian Territory 8
HR - Croazia 7
LK - Sri Lanka 7
AM - Armenia 6
CY - Cipro 6
GE - Georgia 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
NI - Nicaragua 6
BZ - Belize 5
LV - Lettonia 5
MD - Moldavia 5
Totale 61.559
Salva come PNG Salva come JPEG
Città #
Southend 3.452
Santa Clara 2.672
Ashburn 2.513
Singapore 2.408
Fairfield 2.223
Hong Kong 1.820
Stockholm 1.816
Chandler 1.671
Woodbridge 1.618
Hefei 1.275
Chicago 1.274
Jacksonville 1.139
Houston 1.007
Seattle 963
Wilmington 937
San Jose 877
Dearborn 876
Ann Arbor 776
Beijing 769
Nyköping 761
Cambridge 748
Los Angeles 726
London 609
Modena 542
Ho Chi Minh City 500
Seoul 400
Salt Lake City 398
Helsinki 380
The Dalles 369
Council Bluffs 347
Izmir 330
Hanoi 323
New York 295
Dallas 243
Princeton 235
Sofia 216
Milan 209
San Diego 201
Eugene 200
Lauterbourg 197
Bologna 174
Tampa 170
Moscow 169
Elk Grove Village 167
Rome 162
São Paulo 143
Buffalo 138
Shanghai 133
Munich 124
Redwood City 121
Orem 115
Jakarta 114
Frankfurt am Main 106
Tokyo 100
Bremen 94
Falls Church 93
Lancaster 91
Des Moines 85
Fremont 84
Reggio Emilia 80
Dublin 79
Sterling 79
Phoenix 78
Columbus 70
Miami 70
Chennai 69
Brussels 68
Parma 60
Da Nang 57
Guangzhou 55
Naples 55
Warsaw 55
Florence 54
Dulles 53
Haiphong 53
Johannesburg 51
Boardman 49
Baghdad 48
Brooklyn 48
Nanjing 46
Detroit 45
Atlanta 44
Amsterdam 43
Montreal 43
Como 41
Denver 40
Rio de Janeiro 40
Tulare 39
Napoli 37
Norwalk 37
Washington 37
Manchester 36
Catania 35
Mexico City 35
Turin 34
Bari 33
Quito 33
Sydney 33
Tashkent 33
Belo Horizonte 32
Totale 42.725
Salva come PNG Salva come JPEG
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.025
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 571
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 501
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 484
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 464
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 456
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 449
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 448
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 432
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 429
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 424
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 419
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 414
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 411
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 410
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 408
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 408
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 404
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 398
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 393
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 392
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 392
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 384
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 384
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 379
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 379
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 377
Chemo-enzymatic synthesis of levodropropizine 376
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 373
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 371
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 364
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 363
Vegetable cells in Papanicolaou-stained cervical smears 362
Polymeric nanoparticles for the drug delivery to the central nervous system 358
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 357
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 357
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 355
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 352
Nanomedicine: the future for advancing medicine and neuroscience 351
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 351
Brain targeting with polymeric nanoparticles: which administration route should we take? 345
Protein corona and nanoparticles: How can we investigate on? 344
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 343
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 342
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 341
Advances and perspectives for Central Nervous System drug delivery: the interface between nanotechnology and neuroscience 340
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 339
Nanoparticle transport across the blood brain barrier 338
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 338
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 338
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 336
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 332
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 325
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 325
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 323
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 323
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 322
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 321
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 318
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 318
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 318
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 316
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 310
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 310
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 310
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 306
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 305
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 302
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 301
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 301
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 300
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 300
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 298
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 298
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 297
Colloidal systems for CNS drug delivery 295
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 295
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 294
Functionalization of liposomes: microscopical methods for preformulative screening 294
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 294
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 293
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 292
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 292
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 290
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 290
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 289
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 286
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 284
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 280
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 269
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 267
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 266
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 265
Application of poly-L-lactide screws in flat foot surgery: Histological and radiological aspects of bio-absorption of degradable devices 264
Ketorolac tromethamine liposomes: Encapsulation and release studies 262
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 261
Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers 261
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 259
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 258
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 256
Totale 35.904
Salva come PNG Salva come JPEG
Categoria #
all - tutte 225.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 225.563
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.376 0 0 0 0 0 0 0 0 0 834 313 229
2021/20224.031 178 482 379 242 154 210 213 222 483 320 642 506
2022/20234.655 577 548 362 472 544 622 125 411 528 74 190 202
2023/20243.511 165 197 221 285 793 356 401 418 109 107 169 290
2024/202510.855 500 175 228 827 2.043 1.474 851 771 1.053 466 1.099 1.368
2025/202620.792 1.308 808 1.504 2.778 4.373 1.321 2.161 1.026 3.784 1.729 0 0
Totale 62.060